Ontak-like human IL-2 fusion toxin

Ontak(®) is a FDA-approved diphtheria toxin-based recombinant fusion toxin for treatment of human CD25(+) cutaneous T cell lymphoma (CTCL). However, it has been discontinued clinically due to the production issue related to the bacterial expression system with difficult purification. Recently we hav...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunol Methods
Main Authors: Wang, Zhaohui, Zheng, Qian, Zhang, Huiping, Bronson, Roderick T., Madsen, Joren C., Sachs, David H., Huang, Christene A., Wang, Zhirui
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5576150/
https://ncbi.nlm.nih.gov/pubmed/28551309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jim.2017.05.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados